The mechanism of antibacterial action of tetracycline involves
Rationale:
Tetracycline acts by blocking the binding of aminoacyl-tRNA to bacterial ribosomes. This prevents the addition of new amino acids to the growing peptide chain, effectively inhibiting protein synthesis. Tetracycline specifically targets the 30S ribosomal subunit and interferes with tRNA attachment, disrupting bacterial translation without affecting the 50S subunit or peptidyl transferase activity.
A: Binding to a component of the 50S ribosomal subunit incorrectly associates tetracycline with the larger ribosomal subunit, while it actually targets the 30S subunit. This misrepresents the antibiotic's binding site and mechanism.
B: Inhibition of translocase activity misattributes tetracycline’s function. Translocase is involved later in elongation, whereas tetracycline blocks aminoacyl-tRNA binding at the initial decoding site on the ribosome.
D: Selective inhibition of ribosomal peptidyl transferases inaccurately describes tetracycline’s mechanism, which does not affect peptide bond formation catalyzed by peptidyl transferase but rather blocks tRNA entry into the ribosome.
What interleukin receptor antagonist would the nurse anticipate is most likely to be ordered for a patient, 25 years old, who has not responded to traditional antirheumatic drugs?
Rationale:
Anakinra (Kineret) is the interleukin receptor antagonist most likely ordered for a patient unresponsive to traditional antirheumatic drugs. Anakinra specifically blocks the interleukin-1 receptor, reducing inflammation associated with rheumatoid arthritis, especially in patients who do not improve with conventional treatments. Its targeted mechanism makes it appropriate for managing persistent symptoms and preventing joint damage in this demographic.
A: Natalizumab (Tysabri) targets alpha-4 integrin to prevent immune cell migration, primarily used for multiple sclerosis and Crohn's disease, not rheumatoid arthritis or as an interleukin receptor antagonist.
C: Eculizumab (Soliris) inhibits complement protein C5, indicated for rare blood disorders like paroxysmal nocturnal hemoglobinuria, unrelated to interleukin receptor antagonism or arthritis treatment.
D: Adalimumab (Humira) is a TNF-alpha blocker, not an interleukin receptor antagonist, used in rheumatoid arthritis but differs in mechanism from anakinra’s interleukin-1 receptor blockade.
The nurse admits a patient who was newly diagnosed with Kaposi's sarcoma to the unit. The physician has ordered an IV infusion of an interferon. What drug would be appropriate?
Rationale:
Interferon alfa 2b is the appropriate drug for IV infusion in a patient with Kaposi's sarcoma. This interferon subtype has demonstrated antiviral, antiproliferative, and immunomodulatory effects specifically beneficial in treating Kaposi's sarcoma, a malignancy linked to human herpesvirus 8 infection. Its FDA approval and clinical use validate its selection for managing this condition effectively.
A: Interferon beta1a primarily treats multiple sclerosis and lacks significant evidence supporting its use against Kaposi's sarcoma, making it unsuitable for this malignancy's treatment regimen.
B: Interferon gamma 1b is mainly indicated for chronic granulomatous disease and severe malignant osteopetrosis, with no established efficacy in Kaposi's sarcoma therapy.
D: Peginterferon alfa 2b is designed for chronic hepatitis C treatment, focusing on viral suppression rather than the oncogenic mechanisms involved in Kaposi's sarcoma.
All are true EXCEPT: Mycophenolate mofetil:
Rationale:
Mycophenolate mofetil is not given intravenously.
Mycophenolate mofetil is an oral prodrug converted to mycophenolic acid, which selectively inhibits inosine monophosphate dehydrogenase, blocking de novo purine synthesis in lymphocytes. This targeted mechanism suppresses T and B cell proliferation, making it effective in preventing transplant rejection while commonly causing leukopenia as a dose-related adverse effect.
A: Is a prodrug This is accurate because mycophenolate mofetil requires metabolic conversion to the active mycophenolic acid form to exert its immunosuppressive effects.
B: Inhibits inosine monophosphate dehydrogenase, impairing de novo purine synthesis in T and B cells This correctly describes the drug’s mechanism of action that selectively targets lymphocyte proliferation by disrupting guanine nucleotide synthesis.
D: Causes leukopenia Leukopenia is a well-documented adverse effect resulting from bone marrow suppression due to the drug’s impact on rapidly dividing immune cells, confirming this statement’s validity.
In the empiric treatment of severe bacterial infections of unidentified etiology, this drug, often used in combination with an aminoglycoside, provides coverage against many staphylococci
Rationale:
Nafcillin is the drug often used in combination with an aminoglycoside to provide coverage against many staphylococci in empiric treatment of severe bacterial infections of unidentified etiology. Nafcillin is a penicillinase-resistant beta-lactam antibiotic specifically effective against penicillinase-producing staphylococci, making it suitable for empiric therapy targeting these bacteria.
A: Amoxicillin lacks resistance to penicillinase enzymes produced by many staphylococci, limiting its effectiveness in severe staphylococcal infections.
B: Clavulanic acid is a beta-lactamase inhibitor, not an antibiotic by itself, so it cannot provide direct antibacterial coverage against staphylococci.
C: Erythromycin covers some staphylococci but has variable resistance and is less reliable than nafcillin in severe infections requiring empiric coverage.
All of the following drugs are suitable oral therapy for a lower urinary tract infection due to Pseudomonas aeruginosa except
Rationale:
Trimethoprim-sulfamethoxazole is not suitable oral therapy for a lower urinary tract infection caused by Pseudomonas aeruginosa. This bacterium often exhibits resistance to this combination, making it ineffective for treatment. Effective oral agents against Pseudomonas typically include fluoroquinolones like ciprofloxacin and norfloxacin, which have better activity profiles. Carbenicillin is not oral, excluding it from suitable oral options.
A: Norfloxacin Norfloxacin is effective orally against Pseudomonas aeruginosa due to its fluoroquinolone class, which penetrates urinary tissues well and inhibits bacterial DNA gyrase, making it a suitable choice for such infections.
C: Ciprofloxacin Ciprofloxacin is a potent oral fluoroquinolone with strong anti-Pseudomonas activity, widely used for lower urinary tract infections, providing reliable penetration and bacterial eradication in urinary tissues.
D: Carbenicillin Carbenicillin is not administered orally; it is available only parenterally. Therefore, despite its antipseudomonal spectrum, it cannot be considered suitable oral therapy for urinary tract infections.
Your patient taking belatacept becomes pregnant. After discussion with her partner, you, and her health care provider, she decides the best thing to do is continue taking the drug while pregnant. In addition to making this informed decision, what else should she do?
Rationale:
The patient should continue all other drugs as prescribed. Continuing all other medications ensures proper management of her health conditions without abrupt changes that could cause harm. This approach maintains therapeutic stability while monitoring the effects of belatacept during pregnancy, supporting both maternal and fetal well-being under professional guidance.
A: Discontinue all other drugs Abruptly stopping other medications may worsen underlying conditions, risking maternal and fetal health. It disregards the necessity of maintaining stable treatment regimens during pregnancy.
C: Stop taking belatacept immediately Halting belatacept without medical advice could cause transplant rejection or disease flare, jeopardizing both mother and fetus despite the patient's choice to continue the drug.
D: Consult with a genetic counselor Genetic counseling primarily addresses hereditary risks, not medication management or pregnancy drug safety, which are more relevant in this clinical decision-making scenario.
Drug which interfere with the bacterial cell wall synthesis is
Rationale:
Drug which interfere with the bacterial cell wall synthesis is Penicillins and cephalosporins.
Penicillins and cephalosporins disrupt bacterial cell wall synthesis by inhibiting the enzymes responsible for cross-linking peptidoglycan layers. This weakens the cell wall, causing bacterial lysis and death. Their mechanism specifically targets the unique bacterial cell wall structure, making them highly effective against actively dividing bacteria while sparing human cells that lack cell walls.
A: Chloramphenicol inhibits protein synthesis by binding to the 50S ribosomal subunit, not affecting cell wall formation or integrity. It acts intracellularly on bacterial ribosomes rather than the cell envelope.
B: Tetracyclines block bacterial protein synthesis by preventing tRNA attachment to the 30S ribosomal subunit. They do not interfere with the peptidoglycan synthesis essential for bacterial cell walls.
C: Colistin disrupts the bacterial outer membrane of Gram-negative bacteria by interacting with lipopolysaccharides, but it does not inhibit peptidoglycan cross-linking or cell wall biosynthesis directly.
Glucocorticosteroids inhibit:
Rationale:
Glucocorticosteroids inhibit leukotriene C₄ and D₄ synthesis. This is because they suppress the enzyme phospholipase A2, reducing arachidonic acid release and subsequently lowering leukotriene production, which are key mediators in inflammation and allergic reactions. Their primary effect targets leukotriene pathways rather than inhibiting all aspects of arachidonic acid metabolism or other inflammatory mediators directly.
A: Platelet thromboxane A₂ synthesis Platelet thromboxane A₂ synthesis primarily involves cyclooxygenase activity, which glucocorticosteroids do not directly inhibit; their main action is upstream at phospholipase A2, not downstream thromboxane generation.
B: Histamine release Histamine release occurs mainly from mast cells and basophils and is not directly suppressed by glucocorticosteroids, which focus on inhibiting lipid mediator synthesis rather than immediate histamine secretion.
D: Arachidonic acid metabolism Glucocorticosteroids do not inhibit the entire arachidonic acid metabolism but specifically inhibit phospholipase A2, thus reducing substrate availability rather than blocking the whole metabolic pathway.
The semisynthetic penicillin which is destroyed by acid is
Rationale:
Carbenicillin is the semisynthetic penicillin that is destroyed by acid. Carbenicillin is sensitive to acidic environments, which compromises its stability and efficacy when administered orally. This property distinguishes it from other semisynthetic penicillins designed to resist gastric acid degradation, impacting its clinical use primarily through parenteral routes rather than oral administration for effective treatment.
A: Phenoxymethyl penicillin This penicillin is acid-stable and suitable for oral use, resisting stomach acid degradation, thus it does not fit the profile of an acid-destroyed semisynthetic penicillin.
B: Ampicillin Ampicillin maintains stability in acidic conditions, allowing oral administration, so it does not align with the acid-labile characteristic required here.
D: Cloxacillin Cloxacillin is resistant to acid and beta-lactamase, enabling oral use, thereby it is inconsistent with the acid-sensitive nature described for the correct answer.
Which virus has been associated with posttransplant lymphoproliferative disorder?
Rationale:
Epstein-Barr virus has been associated with posttransplant lymphoproliferative disorder. This virus can infect B cells and drive their uncontrolled proliferation, especially in immunosuppressed transplant recipients. The weakened immune system fails to control EBV-infected cells, leading to lymphoproliferative disorders. This link is well-documented in transplant medicine, highlighting EBV's central role in these complications.
A: Cytomegalovirus primarily causes infections in immunocompromised hosts but does not directly induce lymphoproliferative disorders. Its pathogenic effects focus more on organ-specific damage rather than B cell proliferation post-transplant.
B: Herpes simplex virus mainly causes mucocutaneous lesions and encephalitis. It lacks a direct mechanistic association with lymphoproliferative disorders following transplantation or immunosuppression.
D: Human immunodeficiency virus leads to immunodeficiency and opportunistic infections but is not directly implicated in posttransplant lymphoproliferative disorder pathogenesis linked to B cell proliferation.
A 30-year-old woman has been diagnosed with leukemia and will be using an immune modulator for treatment. What will be important to discuss with the patient when the nurse provides patient teaching about her treatment?
Rationale:
The need to use barrier contraceptives while taking the drug is crucial during immune modulator treatment. Immune modulators can be teratogenic or harmful to a developing fetus, so preventing pregnancy is essential. Barrier methods reduce the risk of drug exposure through sexual activity, ensuring safety for both the patient and potential offspring during therapy.
A: The need to continue oral contraceptives does not address the risk of drug interactions or fetal harm associated with immune modulators, making it an insufficient precaution.
C: The need to avoid sexual intercourse is unnecessarily restrictive and not typically required if effective contraception, like barrier methods, is used.
D: The importance of taking an aspirin daily to decrease adverse effects is unrelated since aspirin does not mitigate immune modulator side effects and may cause additional risks.
A 14-year-old girl requests a vaccination for human papillomavirus. After the nurse administers the first dose, which of the following is important to include in the patient's teaching?
Rationale:
The date the patient needs to return to the clinic for the next human papillomavirus dose is important to include in the patient's teaching. HPV vaccination requires multiple doses for optimal effectiveness, so scheduling the follow-up appointment ensures completion of the vaccine series and maximal protection against HPV-related diseases, such as cervical cancer and genital warts.
A: Human papillomavirus prevents all sexually transmitted diseases. This statement is overly broad and inaccurate; HPV vaccination specifically targets HPV strains, not the entire spectrum of sexually transmitted infections.
B: Pap smears are no longer needed after the human papillomavirus vaccination. Pap smears remain essential as the vaccine does not cover all oncogenic HPV types and cervical cancer screening is still necessary.
C: The patient needs to notify the health care provider about pain at the injection site. Minor pain is a common and expected side effect and usually does not require reporting unless severe or persistent beyond typical reactions.
Which one of the following drugs is most likely to be effective against multidrug-resistant strains of M tuberculosis, including those resistant to streptomycin?
Rationale:
Amikacin is most likely to be effective against multidrug-resistant strains of M tuberculosis, including those resistant to streptomycin. Amikacin, an aminoglycoside antibiotic, retains activity against many resistant M tuberculosis strains due to its resistance to aminoglycoside-modifying enzymes. It is often used in second-line therapy for multidrug-resistant tuberculosis, providing a critical option when first-line drugs fail.
B: Clarithromycin lacks reliable efficacy against M tuberculosis and is not standard in treating multidrug-resistant tuberculosis, limiting its utility in resistant cases.
C: Gentamicin, another aminoglycoside, is generally ineffective against M tuberculosis due to poor activity and resistance mechanisms commonly encountered in resistant strains.
D: Meropenem, a carbapenem, has limited intrinsic activity against M tuberculosis and requires combination with clavulanate to enhance effectiveness against resistant strains.
Amoxicillin + Clavulanic acid is active against the following organism except
Rationale:
Amoxicillin + Clavulanic acid is not active against Methicillin resistant Staph. aureus. This combination works by inhibiting beta-lactamase enzymes, restoring amoxicillin's efficacy against beta-lactamase producing bacteria, but MRSA resists through altered penicillin-binding proteins, rendering beta-lactamase inhibitors ineffective against it. Therefore, it cannot overcome MRSA’s unique resistance mechanism.
B: Penicillinase producing Staph. aureus is susceptible because clavulanic acid inhibits penicillinase enzymes, allowing amoxicillin to kill these bacteria effectively, overcoming their beta-lactamase mediated resistance.
C: Penicillinase producing N. gonorrhoeae is targeted since clavulanic acid neutralizes its penicillinase, enabling amoxicillin to be effective against this organism.
D: ß-lactamase producing E. coli is vulnerable due to clavulanic acid’s beta-lactamase inhibition, restoring amoxicillin’s bactericidal activity against these resistant strains.
Antiviral agents that are active against cytomegalovirus (CMV) include which of the following? I. Ganciclovir II. Foscarnet III. Acyclovir
Rationale:
Antiviral agents that are active against cytomegalovirus (CMV) include ganciclovir, foscarnet, and acyclovir. Ganciclovir is the primary treatment for CMV due to its potent activity. Foscarnet is effective against CMV strains resistant to ganciclovir. Although acyclovir primarily targets herpes simplex virus, it has some activity against CMV, especially at higher doses or in combination therapies.
A: Only I is correct Ganciclovir is effective, but excluding foscarnet and acyclovir ignores other active antivirals against CMV, making this choice incomplete and less comprehensive for CMV treatment options.
B: Only III is correct Acyclovir mainly targets herpes simplex virus and is less effective against CMV, so relying solely on acyclovir overlooks the primary and more potent agents like ganciclovir and foscarnet.
C: I and II are correct Ganciclovir and foscarnet are key CMV antivirals, but omitting acyclovir ignores its partial activity and potential adjunctive role against CMV, rendering this choice partially inaccurate.
Antibiotic(s) which inhibit the protein synthesis in cells is/are
Rationale:
Tetracyclines and chloramphenicol inhibit protein synthesis in cells. These antibiotics act by binding to bacterial ribosomes, thereby blocking the translation process and preventing the formation of essential proteins required for bacterial growth and survival. This mechanism specifically targets the protein synthesis machinery, distinguishing them from other antibiotics that interfere with cell wall or nucleic acid synthesis.
A: Sulphonamides and PAS primarily inhibit folic acid synthesis, not protein synthesis. Their action disrupts nucleotide production, affecting DNA replication rather than directly targeting ribosomal function or protein formation in cells.
B: Isoniazid and PAS mainly interrupt mycolic acid and folate synthesis, respectively. They do not interfere with the ribosomal machinery or the translation step of protein synthesis in bacterial cells.
D: Penicillin and cephalosporins inhibit bacterial cell wall synthesis by targeting peptidoglycan cross-linking, which is unrelated to protein synthesis inhibition or ribosomal interference in bacterial cells.
The nurse is caring for a female patient, aged 62, who has been admitted for treatment of metastatic melanoma. What agent would the nurse anticipate the physician is likely to order?
Rationale:
Ipilimumab is the agent the nurse would anticipate for treating metastatic melanoma. This immunotherapy drug enhances the immune system's ability to detect and destroy melanoma cells by blocking CTLA-4, a checkpoint inhibitor, thereby improving survival rates in advanced melanoma cases. It is specifically approved for metastatic melanoma, making it the most appropriate choice for this patient’s condition.
A: Aldesleukin is primarily used for renal cell carcinoma and metastatic melanoma, but its severe toxicity profile and limited use reduce its likelihood as the first choice in current melanoma treatment protocols.
B: Interferon alfa 2b serves mainly as an adjuvant therapy in melanoma, not a first-line agent for metastatic disease, limiting its role in this acute management scenario.
C: Cyclosporine is an immunosuppressant used in transplant patients, unrelated to melanoma treatment, and would counteract immune responses needed to combat metastatic melanoma effectively.
All are true EXCEPT: Azathioprine:
Rationale:
Azathioprine is not administered by continuous infusion. Azathioprine is an oral immunosuppressive drug metabolized to 6-mercaptopurine, affecting cell-mediated immunity and inflammation by inhibiting lymphocyte proliferation. It causes bone marrow suppression, leading to neutropenia and thrombocytopenia. Continuous infusion is not a typical administration route for this medication, distinguishing option C as the exception.
A: Is metabolized to 6-mercaptopurine This is accurate; azathioprine is a prodrug converted into 6-mercaptopurine, which interferes with purine synthesis, essential for DNA replication in rapidly dividing immune cells.
B: Inhibits delayed hypersensitivity (cell-mediated immunity) and those aspects of inflammation that require cell division This correctly describes azathioprine’s immunosuppressive mechanism by targeting lymphocyte proliferation, thereby reducing cell-mediated immune responses and inflammation dependent on mitosis.
D: Causes neutropenia and thrombocytopenia Azathioprine’s bone marrow toxicity can suppress production of white cells and platelets, causing neutropenia and thrombocytopenia, which aligns with the known hematologic adverse effects of the drug.
Your patient is receiving basiliximab and develops cytokine release syndrome. You would expect to see:
Rationale:
Chills are a common symptom of cytokine release syndrome seen in patients treated with basiliximab. Cytokine release syndrome involves rapid immune activation leading to systemic inflammatory symptoms such as fever, chills, and rigors. Basiliximab, an IL-2 receptor antagonist, can trigger this immune response, causing chills as the body reacts to cytokine surges and inflammatory mediators.
A: Coughing rarely characterizes cytokine release syndrome and is more associated with respiratory infections or irritations rather than systemic immune activation.
C: Tremors are not typically prominent in cytokine release syndrome, which predominantly features fever, chills, and hypotension rather than neuromuscular hyperactivity.
D: Weakness may occur but is nonspecific and less directly linked to the acute inflammatory symptoms characteristic of cytokine release syndrome compared to chills.
Tetracyclines are still the first choice drugs for the following disease.
Rationale:
Tetracyclines are still the first choice drugs for granuloma inguinale.
Granuloma inguinale, caused by Klebsiella granulomatis, responds effectively to tetracycline antibiotics due to their ability to inhibit bacterial protein synthesis. These drugs offer a targeted approach, especially when other antibiotics show limited efficacy. Tetracyclines' broad-spectrum activity and intracellular penetration make them ideal for this chronic ulcerative infection treatment.
B: Chancroid treatment primarily involves macrolides or cephalosporins rather than tetracyclines, which are less effective against Haemophilus ducreyi, the causative agent.
C: Syphilis is predominantly managed with penicillin, particularly benzathine penicillin G; tetracyclines serve as alternatives only when penicillin is contraindicated.
D: Gonorrhoea in penicillin-allergic patients is typically treated with cephalosporins or azithromycin, as resistance patterns and efficacy limit tetracycline use.
Tetracyclines are avoided in pregnancy because they can
Rationale:
Tetracyclines are avoided in pregnancy because they can affect the bones and teeth of the fetus. These antibiotics bind to calcium ions, leading to discoloration and hypoplasia of fetal teeth and impairing bone growth, which can cause permanent developmental defects, making their use contraindicated during pregnancy to prevent such teratogenic effects on fetal skeletal formation.
A: Cause abortions This option does not capture the primary teratogenic risk of tetracyclines. They are not primarily associated with inducing abortion but with fetal developmental toxicity, especially related to teeth and bone abnormalities.
B: Cause excessive postpartum hemorrhage Tetracyclines lack any direct mechanism or evidence linking them to increased bleeding postpartum, making this an unrelated and inaccurate concern during pregnancy.
D: Cause excessive vomiting in the mother Vomiting is not a significant or unique side effect of tetracyclines in pregnancy and does not justify avoidance; other drugs are more commonly associated with severe maternal nausea.
The nurse is caring for a patient who has a diagnosis of chronic hepatitis B infection and has been prescribed an immune stimulant. After teaching the patient about the treatment plan, how might the nurse evaluate the effectiveness of teaching?
Rationale:
The patient can state specific measures to avoid adverse effects.
This answer demonstrates understanding of the treatment’s safety aspects, emphasizing the importance of recognizing and preventing potential adverse reactions. It reflects comprehensive teaching evaluation by ensuring the patient can actively participate in managing side effects, which is crucial for chronic hepatitis B treatment involving immune stimulants that may cause significant adverse effects.
A: The patient knowing medication location does not confirm understanding of treatment safety or management, which is critical for evaluating teaching effectiveness in chronic hepatitis B care.
B: Identifying who administers the medication focuses on logistics rather than the patient’s comprehension of treatment implications or adverse effect prevention.
C: Recognizing positive effects overlooks the necessity of identifying and preventing potential adverse effects, which is vital for safe and effective immune stimulant therapy.
Gram-negative organisms are largely insensitive to benzyl penicillin because
Rationale:
Gram-negative organisms are largely insensitive to benzyl penicillin because benzyl penicillin is not able to penetrate deeper into the lipoprotein-peptidoglycan multilayer cell wall of gram-negative bacteria. This outer membrane barrier restricts the antibiotic’s access to its target sites, reducing its efficacy. The unique cell wall structure prevents effective drug accumulation inside the bacterial cell.
A: They produce large quantities of penicillinase fails because while some bacteria produce penicillinase, many gram-negative bacteria resist benzyl penicillin primarily due to outer membrane impermeability, not enzymatic degradation alone.
B: They do not utilize D-alanine whose incorporation in the cell wall is inhibited by benzyl penicillin incorrectly suggests a metabolic difference that does not exist; gram-negative bacteria do incorporate D-alanine in their peptidoglycan.
D: Both (a) and (b) is inaccurate since neither penicillinase production nor lack of D-alanine utilization fully explains insensitivity; the main reason is the antibiotic’s inability to penetrate the outer membrane.
Which of the following statements about vancomycin is accurate?
Rationale:
Vancomycin is not susceptible to penicillinase.
Vancomycin’s mechanism involves inhibiting cell wall synthesis by binding to D-alanyl-D-alanine termini, not penicillin-binding proteins, making it resistant to degradation by penicillinase enzymes that target beta-lactam antibiotics, thus preserving its efficacy against resistant bacteria such as MRSA.
A: It is bacteriostatic Vancomycin is bactericidal, actively killing bacteria by disrupting cell wall synthesis rather than merely inhibiting their growth.
B: It binds to PBPs Vancomycin does not bind to penicillin-binding proteins; it targets the D-alanyl-D-alanine residues within the cell wall precursors.
D: It has the advantage of oral bioavailability Vancomycin poorly absorbs orally, typically requiring intravenous administration for systemic infections.
What interleukin receptor antagonist would the nurse anticipate is most likely to be ordered for a patient, 25 years old, who has not responded to traditional antirheumatic drugs?
Rationale:
Anakinra (Kineret) is the interleukin receptor antagonist most likely ordered for a 25-year-old patient unresponsive to traditional antirheumatic drugs. Anakinra specifically blocks interleukin-1 receptors, reducing inflammation in rheumatoid arthritis. It is commonly used when conventional treatments fail, targeting inflammatory pathways distinct from tumor necrosis factor inhibitors, making it appropriate for patients needing alternative biologic therapy.
A: Natalizumab (Tysabri) targets integrin molecules to prevent immune cell migration, primarily used in multiple sclerosis and Crohn’s disease, not rheumatoid arthritis, thus unsuitable for this patient's condition.
C: Eculizumab (Soliris) inhibits complement protein C5, used mainly for rare hematologic disorders like paroxysmal nocturnal hemoglobinuria, lacking action on interleukin pathways relevant to arthritis.
D: Adalimumab (Humira) is a tumor necrosis factor inhibitor, not an interleukin receptor antagonist, making it a different class of biologic therapy than what the question specifies.
The following are successfully used in the management of allergic rhinitis (hayfever) apart from:
Rationale:
Nasal terbutaline is not successfully used in the management of allergic rhinitis (hayfever). Nasal budesonide, desensitization with allergen mixes, and nasal sodium cromoglicate are proven treatments targeting inflammation, immune response modulation, and symptom relief. Terbutaline, a bronchodilator, is primarily used for asthma, lacking efficacy in allergic rhinitis symptom control or immune modulation.
A: Nasal budesonide effectively reduces nasal inflammation and congestion through corticosteroid action, providing significant symptom relief in allergic rhinitis, making it a standard treatment option.
B: Desensitization with allergen mixes systematically retrains the immune system to tolerate allergens, reducing hypersensitivity and resulting in long-term symptom improvement in allergic rhinitis patients.
C: Nasal sodium cromoglicate stabilizes mast cells, preventing histamine release and subsequent allergic symptoms, thus effectively managing allergic rhinitis without systemic side effects.
Which one of the following statements about cefotetan is accurate?
Rationale:
Cefotetan's antibacterial spectrum includes Bacteroides fragilis. Cefotetan is a second-generation cephalosporin notable for its activity against anaerobic bacteria, particularly Bacteroides fragilis, making it effective in treating infections involving this pathogen. Its unique beta-lactamase stability enhances efficacy against anaerobes, distinguishing it from many other cephalosporins that lack such comprehensive anaerobic coverage.
A: It is active against MRSA strains MRSA strains exhibit resistance mechanisms, including altered penicillin-binding proteins, that cefotetan cannot overcome, limiting its effectiveness against these resistant bacteria.
B: It is the drug of choice in community-acquired pneumonia Cefotetan is not preferred for community-acquired pneumonia, as other agents like macrolides or respiratory fluoroquinolones are more effective for typical and atypical pathogens involved.
C: It is a fourth-generation cephalosporin Cefotetan belongs to the second-generation cephalosporins; fourth-generation cephalosporins, like cefepime, have broader gram-negative coverage and different clinical indications.
Which out of the following antibiotics penetrates blood-CSF barrier the best
Rationale:
Chloramphenicol penetrates the blood-CSF barrier the best. Chloramphenicol is highly lipophilic, enabling effective diffusion through the blood-brain barrier into the cerebrospinal fluid. It attains therapeutic concentrations in the CSF, making it suitable for treating central nervous system infections. Its molecular characteristics and minimal protein binding enhance its penetration, unlike many other antibiotics with limited access to the CSF compartment.
A: Erythromycin Erythromycin poorly crosses the blood-CSF barrier due to its large molecular size and extensive protein binding, limiting its therapeutic concentration in cerebrospinal fluid. It is less effective for central nervous system infections.
B: Gentamicin Gentamicin is hydrophilic and highly polar, preventing substantial diffusion across the blood-CSF barrier. Its minimal penetration restricts its utility for treating infections within the cerebrospinal fluid.
C: Tetracycline Tetracycline’s penetration into the CSF is limited by moderate protein binding and less lipophilicity compared to chloramphenicol, resulting in subtherapeutic levels in the cerebrospinal fluid.
A recent laboratory results indicated an “undetectable†human immunodeficiency virus viral load. What is the nurse's best response?
Rationale:
An undetectable HIV viral load requires educating the patient about continued medication adherence and ongoing laboratory monitoring.
This response emphasizes the importance of maintaining antiretroviral therapy to keep the viral load suppressed and prevent resistance. Continuous monitoring ensures early detection of any viral rebound, supporting long-term health and preventing transmission, aligning with current HIV management standards.
A: Inform the patient that he must be seen immediately because the undetectable viral load indicates that his medication stopped working. This inaccurately interprets undetectable viral load as treatment failure, which contradicts established HIV treatment principles.
B: Have the patient reschedule his clinic visit. Postponing follow-up neglects necessary routine monitoring essential for sustained viral suppression and overall patient health management.
C: Congratulate the patient on his treatment success. While positive reinforcement is important, it omits critical information about the need for ongoing medication and monitoring to maintain viral suppression.